The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

DRASTICO Study Compares Drug-Eluting Technologies in Femoropopliteal Lesions

July 17, 2019 -- Findings from the DRASTICO study, which compared drug-coated balloons (DCBs) and drug-eluting stents (DESs) for treating complex femoropopliteal arterial lesi…

Study Compares Endovascular Strategies for Treating Femoropopliteal Disease

July 17, 2019 -- Rongzhou He, MD, et al conducted a study of restenosis prevention with drug-eluting stents (DESs) or covered stents (CSs) in femoropopliteal arterial occlusiv…

Microvascular Disease May Be Linked to Higher Risk of Leg Amputations

July 8, 2019 -- The American Heart Association (AHA) announced the publication of a study demonstrating that microvascular disease is independently associated with a higher ri…

LUTONIX® DCB: Changing the Treatment Landscape for BTK Arteries

With Marianne Brodmann, MD; Marc Sirvent, MD, FEBVS; Ralf Langhoff, MD; Christoph A. Binkert, MD, FCIRSE, FSIR; and Luis Mariano Palena, MD

May 2019—In response to the LUTONIX Below-the-Knee (BTK) Investigational Device Exemption (IDE) Trial results, experts share their experience with LUTONIX® Drug-Coated Balloons (DC…

Leave the Right Thing Behind: Redefining Strategies for Limb Salvage

With Vincenzo Pestrichella, MD

May 2019—Discussing an algorithmic approach for simple to complex femoropopliteal lesions.

Worse Outcomes Seen With Loss to Follow-Up at 1 Year After Lower Extremity Interventions

June 28, 2019 -- In Vascular Medicine, Grace J. Wang, MD, et al published a study showing that loss to follow-up (LTF) at 1 year after lower extremity peripheral vascular inte…

RESULTS Registry Will Evaluate 2-Year Outcomes With Ra Medical's DABRA Excimer Laser System

June 19, 2019 -- Ra Medical Systems, Inc. announced it is conducting a study to demonstrate the effectiveness of the company's DABRA (Destruction of Arteriosclerotic Block…

FDA Paclitaxel Advisory Meeting Day 1: Panel Addresses Updated Data, Signal Presence, Class Effect, Missing Data, Subgroups, and Causes of Death

June 19, 2019 -- Among efforts to explore and address concerns raised by recent meta-analysis data that found an increased mortality signal in patients treated with lower extr…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.